BamSEC and AlphaSense Join Forces
Learn More

Tarsus Pharmaceuticals Inc.

NASDAQ: TARS    
Share price (12/23/24): $54.41    
Market cap (12/23/24): $2.080 billion

Indentures Filter

EX-4.1
from 8-K 12 pages Tarsus Pharmaceuticals, Inc. [Form Of] Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.5
from S-3ASR 87 pages Indenture Between Tarsus Pharmaceuticals, Inc. as Issuer and [Trustee] as Trustee Dated as of , 20 Providing for the Issuance of Debt Securities in Series Tarsus Pharmaceuticals, Inc. Reconciliation and Tie Between the Trust Indenture Act of 1939 and the Indenture
12/34/56
EX-4.5
from S-3 87 pages Indenture Between Tarsus Pharmaceuticals, Inc. as Issuer and [Trustee] as Trustee Dated as of , 20 Providing for the Issuance of Debt Securities in Series Tarsus Pharmaceuticals, Inc. Reconciliation and Tie Between the Trust Indenture Act of 1939 and the Indenture
12/34/56
EX-4.2
from 10-K 4 pages Description of Tarsus Pharmaceuticals, Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-3 87 pages Indenture Between Tarsus Pharmaceuticals, Inc. as Issuer and [Trustee] as Trustee Dated as of , 20 Providing for the Issuance of Debt Securities in Series Tarsus Pharmaceuticals, Inc. Reconciliation and Tie Between the Trust Indenture Act of 1939 and the Indenture
12/34/56
EX-4.2
from 10-K 4 pages Description of Tarsus Pharmaceuticals, Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-1/A 41 pages Tarsus Pharmaceuticals, Inc. Amended and Restated Investors’ Rights Agreement September 24, 2020
12/34/56
EX-4.1
from S-1/A 3 pages Indenture or similar
12/34/56